Breeding Tobacco for Health
The Newcotiana project aims to modify the composition and, therefore, the use we make of tobacco plants, enriching them with substances of high added value. For this, the Newcotiana scientists will employ highly precise breeding technologies, such as the CRISPR technique, and apply them to breeding cultivated tobacco and its relative species N. benthamiana as improved biofactories. In this way, it is intended to revalue the traditional cultivation of tobacco and, at the same time, to improve our manufacturing capacity for health-related bioproducts, such as vaccines, antibodies and other important small molecules with health-promoting properties.
Latest news: Newcotiana partners release the genome of the biofactory plant N. benthamiana for fighting COVID-19 pandemic. More information at: https://nbenth.com
Tobacco; Molecular Farming; CRISPR; New Plant Breeding Techniques. We receive funding from @EU_H2020 Res&Innov Pgrm; tweets reflect only views of project owner
Winds of change? European Greens fight over a revision of EU GMO law. https://european-biotechnology.com/needful-things/videos/videos/european-greens-fight-over-a-revision-of-eu-gmo-law.html
Oh god I love this paper! I wish it had come out 3 years ago when I was making new overexpression vectors! "A strong terminator is defined by its capacity to promote precise termination, thus decreasing the level of unpolyadenylated transcripts and siRNA production." https://twitter.com/ThePlantJournal/status/1287678606697811968
Generating transgenic lines? Pay attention to the terminator sequence. Poor efficiency in transcription termination, loosely defined poly(A) sites and certain intron/terminator combinations can induce siRNA production from transgenes. https://doi.org/10.1111/tpj.14907
MEDICAGO BEGINS PHASE I CLINICAL TRIALS FOR ITS COVID-19 VACCINE CANDIDATE @medicagoinc @ISPMF @PharmaFactory https://www.medicago.com/en/newsroom/medicago-begins-phase-i-clinical-trials-for-its-covid-19-vaccine-candidate/